ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC

Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival

IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours

Higher BMI may be linked with worse survival among SBS88 positive CRC patients

MatchMiner: An open-source AI precision medicine trial matching platform

Test identifies tumour-infiltrating cell densities as prognostic biomarkers across a pan-cancer cohort

Current indications and challenges with IORT in the Philippines

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC

Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical benefit in patients with resectable NSCLC

Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC

LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC